Literature DB >> 10456248

Glucocorticoids and muscle catabolism.

P O Hasselgren1.   

Abstract

Glucocorticoids inhibit protein synthesis and stimulate protein degradation in skeletal muscle and are an important factor in the development of muscle atrophy in various catabolic conditions. Glucocorticoid-stimulated muscle protein breakdown is primarily caused by ubiquitin-proteasome-dependent proteolysis although calcium-dependent protein degradation may also be involved. In certain catabolic conditions, including sepsis, an interaction between glucocorticoids and proinflammatory cytokines is important for the stimulation of muscle protein breakdown.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456248     DOI: 10.1097/00075197-199905000-00002

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  83 in total

1.  Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle.

Authors:  Nima Alamdari; Ira J Smith; Zaira Aversa; Per-Olof Hasselgren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-10       Impact factor: 3.619

2.  Inflammatory and protein metabolism signaling responses in human skeletal muscle after burn injury.

Authors:  Edward K Merritt; James M Cross; Marcas M Bamman
Journal:  J Burn Care Res       Date:  2012 Mar-Apr       Impact factor: 1.845

3.  Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles.

Authors:  Lydie Combaret; Daniel Taillandier; Dominique Dardevet; Daniel Béchet; Cécile Rallière; Agnès Claustre; Jean Grizard; Didier Attaix
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

4.  Sepsis and glucocorticoids downregulate the expression of the nuclear cofactor PGC-1beta in skeletal muscle.

Authors:  Michael J Menconi; Zoltan P Arany; Nima Alamdari; Zaira Aversa; Patricia Gonnella; Patrick O'Neal; Ira J Smith; Steven Tizio; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-07-20       Impact factor: 4.310

5.  Glucocorticoids differentially regulate degradation of MyoD and Id1 by N-terminal ubiquitination to promote muscle protein catabolism.

Authors:  Liping Sun; Julie S Trausch-Azar; Louis J Muglia; Alan L Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-22       Impact factor: 11.205

Review 6.  Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation.

Authors:  Per-Olof Hasselgren; Nima Alamdari; Zaira Aversa; Patricia Gonnella; Ira J Smith; Steven Tizio
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

Review 7.  Calpain activity and muscle wasting in sepsis.

Authors:  Ira J Smith; Stewart H Lecker; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

8.  The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn.

Authors:  Marc G Jeschke; Celeste C Finnerty; Oscar E Suman; Gabriela Kulp; Ronald P Mlcak; David N Herndon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

9.  Extracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure.

Authors:  Mitsuharu Okutsu; Jarrod A Call; Vitor A Lira; Mei Zhang; Jean A Donet; Brent A French; Kyle S Martin; Shayn M Peirce-Cottler; Christopher M Rembold; Brian H Annex; Zhen Yan
Journal:  Circ Heart Fail       Date:  2014-02-12       Impact factor: 8.790

Review 10.  11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.

Authors:  T M Stulnig; W Waldhäusl
Journal:  Diabetologia       Date:  2003-12-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.